Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Abpro Bio Co., Ltd.
  6. Summary
    A195990   KR7195990007

ABPRO BIO CO., LTD.

(A195990)
 SummaryChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Korea Stock Exchange
01/17/2022 01/18/2022 01/19/2022 01/20/2022 01/21/2022 Date
877 849 828 832 823 Last
995030 1646864 1314055 1045412 1125947 Volume
-1.90% -3.19% -2.47% +0.48% -1.08% Change
Estimated financial data (e)
Sales 2019 31 930 M 26,8 M 26,8 M
Net income 2019 -37 869 M -31,8 M -31,8 M
Net Debt 2019 26 480 M 22,2 M 22,2 M
P/E ratio 2019 -2,75x
Yield 2019 -
Sales 2020 49 282 M 41,3 M 41,3 M
Net income 2020 -58 972 M -49,5 M -49,5 M
Net cash position 2020 19 491 M 16,4 M 16,4 M
P/E ratio 2020 -6,28x
Yield 2020 -
Capitalization 214 B 180 M 180 M
EV / Sales 2019 5,28x
EV / Sales 2020 8,97x
Nbr of Employees 43
Free-Float 90,9%
More Financials
Company
Abpro Bio Co., Ltd., formerly Ugint Co., Ltd., is a Korea-based company engaged in machine tools manufacturing. The Company produces and distributes small sized machining centers for notebooks, smart phones, tablet personal computers, mobile phones, base plates, light emitting diode (LED) and light crystal display (LCD) television panels, automobile parts, motorbikes parts and aircraft parts. The Company also... 
More about the company
All news about ABPRO BIO CO., LTD.
2021Abpro Bio Co., Ltd. announced that it has received KRW 5.999999552 billion in funding
CI
2021Abpro Bio Co., Ltd. announced that it expects to receive KRW 4.99999895 billion in fund..
CI
2021Abpro Bio Co., Ltd. announced that it has received KRW 15 billion in funding from Merit..
CI
2021Abpro Bio Co., Ltd. announced that it expects to receive KRW 15 billion in funding from..
CI
2020Abpro Bio Co., Ltd. announced that it has received KRW 10 billion in funding from Korea..
CI
2020An unknown buyer cancelled the acquisition of 75% stake in UG Asset Co., Ltd. from Abpr..
CI
2020Microtech Co.,Ltd cancelled the acquisition of 80% stake in Vitro Corporation from Abpr..
CI
2020Abpro Bio Co., Ltd. announced that it expects to receive KRW 10 billion in funding from..
CI
2020ABPRO BIO CO., LTD.(KOSDAQ : A195990) added to S&P Global BMI Index
CI
2019An unknown buyer agreed to acquire 75% stake in UG Asset Co., Ltd. from Abpro Bio Co., ..
CI
2019Microtech Co.,Ltd agreed to acquire 80% stake in Vitro Corporation from Abpro Bio Co., ..
CI
2019Abpro Bio International, Inc. announced that it has received KRW 18.6608 billion in fun..
CI
2019Abpro Bio Co., Ltd. announced that it has received KRW 19.999999134 billion in funding
CI
2019Abpro Bio Co., Ltd. announced that it has received KRW 14 billion in funding
CI
2019Abpro Bio Co., Ltd. announced that it expects to receive KRW 14 billion in funding
CI
More news
News in other languages on ABPRO BIO CO., LTD.

- No features available -

More news
Chart ABPRO BIO CO., LTD.
Duration : Period :
Abpro Bio Co., Ltd. Technical Analysis Chart | A195990 | KR7195990007 | MarketScreener
Technical analysis trends ABPRO BIO CO., LTD.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers and Directors
Pui Chan Ian Yan Co-Chief Executive Officer & Director
Jin-Sang Yang Co-Chief Executive Officer & Director
Jae-Hong Jeon Independent Director
Gab-Jin Kang Independent Director
Ki-Chul An Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ABPRO BIO CO., LTD.-14.72%180
ESTUN AUTOMATION CO., LTD-0.81%3 512
BYSTRONIC AG-0.78%2 873
KENNAMETAL INC.-4.76%2 861
SHENZHEN YINGHE TECHNOLOGY CO., LTD-15.04%2 709
DMG MORI CO., LTD.-4.10%2 077